Skip to main content
. 2020 Sep 29;93(2):1180–1183. doi: 10.1002/jmv.26467

Table 1.

Baseline characteristics and outcomes

Variables SARS‐CoV‐2 infection and Mycoplasma pneumoniae IgM positive (n = 79) SARS‐CoV‐2 infection but M. pneumoniae IgM negative (n = 60) P Value
Characteristics
Age in years, mean (SD) 62.3 (16.3) 62.2 (15.6) .95
Male sex, n (%) 55 (69.6) 30 (50.0) .02
Smoking, n (%) 14 (17.7) 12 (20.0) .73
Hypertension, n (%) 35 (44.3) 35 (58.3) .10
Coronary artery disease, n (%) 3 (3.8) 5 (8.3) .26
Obesity (BMI > 30), n (%) 19 (24.1) 29 (48.3) <.01
Diabetes, n (%) 23 (29.1) 31 (51.7) .01
Chronic respiratory disease, n (%) 10 (12.7) 9 (15.0) .69
Chronic kidney disease, n (%) 11 (13.9) 7 (11.7) .69
Fever > 38°C, n (%) 51 (64.6) 45 (75.0) .19
Course
Invasive mechanical ventilation, n (%) 26 (32.9) 15 (25.0) .31
Intensive care admission, n (%) 29 (36.7) 18 (30.0) .41
Outcomes
Renal replacement therapy, n (%) 9 (11.4) 3 (5.0) .18
Death, n (%)a 38/79 (48.1) 17/60 (28.3) .02

Abbreviations: BMI, body mass index; IgM, immunoglobulin M; SD, standard deviation.

a

One patient in mycoplasma IgM negative group was still in hospital at the time of chart review.